CNBC   |  July 16, 2014

John Paulson on Allergan as Valeant takeover target

John Paulson, founder of hedge fund firm Paulson & Co., said Allergan shares could be worth $222 a share as a result of a potential takeover by Valeant.

Share This:

Sorry, we do not have a transcript available for this video at this time.